167 related articles for article (PubMed ID: 11802251)
1. Serum KL-6 levels in pediatric patients: reference values for children and levels in pneumonia, asthma, and measles patients.
Imai T; Takase M; Takeda S; Kougo T
Pediatr Pulmonol; 2002 Feb; 33(2):135-41. PubMed ID: 11802251
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia.
Arai Y; Obinata K; Sato Y; Hisata K; Tadokoro R; Tawa T; Kinoshita K
Eur J Pediatr; 2001 Jul; 160(7):425-9. PubMed ID: 11475580
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
4. The role of serum KL-6 measurement in common pediatric respiratory infections.
Kubota M; Haruta T
J Infect Chemother; 2006 Feb; 12(1):22-4. PubMed ID: 16506085
[TBL] [Abstract][Full Text] [Related]
5. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
6. KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Kohno N; Yokoyama A; Kondo K
Intern Med; 2000 Dec; 39(12):1004-5. PubMed ID: 11197780
[No Abstract] [Full Text] [Related]
7. Elevated KL-6 levels in fatal measles pneumonia.
Narita M; Nakayama M; Yamada S; Togashi T
Eur J Pediatr; 2001 Jul; 160(7):454-5. PubMed ID: 11475589
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia.
Hamada H; Kohno N; Akiyama M; Hiwada K
Chest; 1992 Mar; 101(3):858-60. PubMed ID: 1541162
[TBL] [Abstract][Full Text] [Related]
9. Circulating KL-6 levels in patients with drug induced pneumonitis.
Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
[TBL] [Abstract][Full Text] [Related]
10. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases.
Fukaya S; Oshima H; Kato K; Komatsu Y; Matsumura H; Ishii K; Miyama H; Nagai T; Tanaka I; Mizutani A; Katayama M; Yoshida S; Torikai K
Rheumatol Int; 2000; 19(6):223-5. PubMed ID: 11063292
[TBL] [Abstract][Full Text] [Related]
11. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy.
Sakuma T; Takahashi K; Ohya N; Usuda K; Handa M
Surg Today; 1999; 29(2):121-8. PubMed ID: 10030736
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of KL-6, a marker of interstitial pneumonia, in cases of HCV-associated chronic liver disease.
Suzuki K; Takada H; Oka S; Kanouzawa S; Iimuro M; Kitazumi Y; Arima T; Ohyama R; Kuwayama H
Intern Med; 2003 Aug; 42(8):650-4. PubMed ID: 12924486
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis.
Kobayashi J; Kitamura S
Chest; 1996 May; 109(5):1276-82. PubMed ID: 8625680
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
Bandoh S; Fujita J; Ohtsuki Y; Ueda Y; Hojo S; Tokuda M; Dobashi H; Kurata N; Yoshinouchi T; Kohno N; Takahara J
Ann Rheum Dis; 2000 Apr; 59(4):257-62. PubMed ID: 10733471
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
[TBL] [Abstract][Full Text] [Related]
16. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis.
Inoue Y; Nishimura K; Shiode M; Akutsu H; Hamada H; Fujioka S; Fujino S; Yokoyama A; Kohno N; Hiwada K
Tuber Lung Dis; 1995 Jun; 76(3):230-3. PubMed ID: 7548906
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia.
Tanaka M; Tanaka K; Fukahori S; Fujimatsu Y; Jojima H; Shiraishi K; Honda J; Oizumi K
Hematology; 2002 Apr; 7(2):105-8. PubMed ID: 12186700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
